CRB-486

N/A

Report date: 2024/02/23 17:49:49

Base Information

Drug NameCRB-486
Drug Alias NameCRB-A4CRB-486
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionSH3 domain-containing YSC84-like protein 1 modulators
TargetsSH3 domain-containing YSC84-like protein 1
Therapy Area/IndicationsAcute Kidney InjuryDiabetic NephropathiesMetabolic Dysfunction-Associated Steatotic Liver Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCelros Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCelros Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsAcute Kidney InjuryDiabetic NephropathiesMetabolic Dysfunction-Associated Steatotic Liver Disease +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A